Zemplar (Paricalcitol) Capsule shortage
Not a nationwide shortage — AbbVie has told the FDA it is discontinuing its paricalcitol capsules. The FDA lists this under “To be discontinued” as of Oct 6, 2026: a company stopping its own product. 4 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
AbbVie is permanently stopping production of Zemplar (paricalcitol) capsules. Generic paricalcitol capsules in 1 mcg and 2 mcg strengths are still listed as available from other manufacturers who have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this medicine? See the ‘What to do’ note from Dr. Brian Staiger, PharmD →Is Zemplar still in shortage? — status as of Oct 6, 2026
Still listed as “To be discontinued” as of Oct 6, 2026. AbbVie is stopping its own version only; 4 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are in the green card, and the Supply-Risk rating counts them too.
Shortage timeline
-
Oct 7, 2025Currently in shortage2 of 2 products affected.
-
Oct 7, 2025First reported to the FDA2 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Zemplar products are affected — by company
Company: AbbVie Inc. 📞 800-633-9110 2 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Zemplar Capsule, 2 ug | 2 ug | — | Discontinuation of the manufacture of the drug | — |
| To Be Discontinued | Zemplar Capsule, 1 ug | 1 ug | — | Discontinuation of the manufacture of the drug | — |
These rows are company reports to the FDA for Paricalcitol Capsule — they do not cover every company that lists this medicine. A company appears here only if it told the FDA it has a supply problem, so other companies may still have stock. That’s the basis for the Where else can I get Zemplar or its generic? options further down this page.
Why is AbbVie discontinuing Zemplar?
AbbVie has reported to the FDA that they are permanently stopping the manufacturing of their brand-name Zemplar paricalcitol capsules. This affects both the 1 mcg and 2 mcg capsule strengths — both come in 30-count bottles. AbbVie did not share a specific public reason for why they made this decision, just that they are discontinuing production of these two products.
It's worth knowing that this report covers only AbbVie's Zemplar capsules. Other manufacturers may still produce paricalcitol capsules and are listed separately on this page.
Based on the company-reported reason(s) and notes on file with the FDA for Paricalcitol Capsule, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as companies report changes.
What should I do if I take Zemplar?
Paricalcitol capsules are currently on the FDA shortage list. This note affects both strengths — the 1 microgram (ug) and 2 ug capsules — because the manufacturer reporting this shortage, AbbVie (the brand Zemplar), has listed both for discontinuation of manufacture. Because this is a discontinuation rather than a temporary delay, the supply issue from this maker may be permanent.
Here is an important point for reassurance: this report reflects only AbbVie. The same medicine, paricalcitol, in both the 1 ug and 2 ug strengths, is still listed by several other makers. So while the brand version is being discontinued, the medicine itself is not gone from the market.
What you can do:
- Do not stop, skip, or change your dose on your own. Keep taking paricalcitol as prescribed.
- Ask your pharmacy whether they can source the same medicine (paricalcitol 1 ug or 2 ug) from another maker such as Time Cap, Dr. Reddy's, Bryant Ranch, or Bionpharma. They can check wholesalers, though it may not be in local stock right away.
- If your exact product cannot be found, ask your prescriber or pharmacist about the best option for you.
Manufacturer contact numbers are listed on this page for reference, though your pharmacy usually makes these calls. This is general national information and may not match your local pharmacy's actual stock.
- Ask your pharmacy to check other companies’ versions, other strengths, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Zemplar or its generic?
FDA shortages are company-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every company that lists paricalcitol capsules is necessarily short. Below are the other listings in the current FDA NDC Directory that are not reported in shortage: the same medicine from companies that haven’t reported a problem (the reporting company is excluded), and other dosage forms. These are generic versions of Zemplar — a switch from the brand goes through your pharmacist or prescriber. Some listings are repackagers, which relabel another company’s product. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine from other companies (not reporting a shortage)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from companies that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Paricalcitol | PARICALCITOL 1 ug/1 | Capsule, Liquid Filled · Oral | TIME CAP LABORATORIES, INC | 49483-0687-03 |
| Paricalcitol | PARICALCITOL 2 ug/1 | Capsule, Liquid Filled · Oral | TIME CAP LABORATORIES, INC | 49483-0688-03 |
| Paricalcitol | PARICALCITOL 4 ug/1 | Capsule, Liquid Filled · Oral | TIME CAP LABORATORIES, INC | 49483-0689-03 |
| Paricalcitol | PARICALCITOL 1 ug/1 | Capsule, Liquid Filled · Oral | Dr. Reddy's Laboratories Limited | 55111-0663-01 |
| Paricalcitol | PARICALCITOL 2 ug/1 | Capsule, Liquid Filled · Oral | Dr. Reddy's Laboratories Limited | 55111-0664-01 |
| Paricalcitol | PARICALCITOL 4 ug/1 | Capsule, Liquid Filled · Oral | Dr. Reddy's Laboratories Limited | 55111-0665-01 |
| Paricalcitol | PARICALCITOL 1 ug/1 | Capsule · Oral | Bryant Ranch Prepack | 63629-2452-01 |
| Paricalcitol | PARICALCITOL 2 ug/1 | Capsule · Oral | Bryant Ranch Prepack | 63629-2453-01 |
| Paricalcitol | PARICALCITOL 1 ug/1 | Capsule · Oral | Bionpharma Inc. | 69452-0145-13 |
| Paricalcitol | PARICALCITOL 2 ug/1 | Capsule · Oral | Bionpharma Inc. | 69452-0146-13 |
| Paricalcitol | PARICALCITOL 4 ug/1 | Capsule · Oral | Bionpharma Inc. | 69452-0147-13 |
Other dosage forms of paricalcitol
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 18 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Paricalcitol 1 ug | TIME | 30 capsules | $1.277 | AB | Availability likely |
| Paricalcitol 1 ug | Aurobindo | 30 capsules | $1.277 | — | Availability likely |
| Paricalcitol 1 ug | Bionpharma | 30 capsules | $1.277 | AB | Availability likely |
| Paricalcitol 2 ug | TIME | 30 capsules | $2.589 | AB | Availability likely |
| Paricalcitol 2 ug | Aurobindo | 30 capsules | $2.589 | — | Availability likely |
| Paricalcitol 2 ug | Bionpharma | 30 capsules | $2.589 | AB | Availability likely |
| Zemplar 2 ug | AbbVie | 30 capsules | — | — | FDA listed |
| Paricalcitol 2 ug | MARKSANS | 30 capsules | — | AB | FDA listed |
| Paricalcitol 2 ug | Dr. | 100 capsules | — | AB | FDA listed |
| Paricalcitol 2 ug | Bryant | 30 capsules | — | AB | FDA listed |
| Paricalcitol 2 ug | Amneal | 30 capsules | — | AB | FDA listed |
| Paricalcitol 2 ug | Bryant | 30 capsules | — | AB | FDA listed |
| Zemplar 1 ug | AbbVie | 30 capsules | — | — | FDA listed |
| Paricalcitol 1 ug | MARKSANS | 30 capsules | — | AB | FDA listed |
| Paricalcitol 1 ug | Dr. | 100 capsules | — | AB | FDA listed |
| Paricalcitol 1 ug | Bryant | 30 capsules | — | AB | FDA listed |
| Paricalcitol 1 ug | Amneal | 30 capsules | — | AB | FDA listed |
| Paricalcitol 1 ug | Bryant | 30 capsules | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Zemplar — that fall in the same broad treatment class (hyperparathyroid tx agents - vitamin d analog-type) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & classification for pharmacists and billers
Where does this data come from?
Other endocrinology/metabolism shortages
Zemplar shortage FAQs
Is Zemplar still in shortage?
Which strengths of Zemplar are affected?
Which Zemplar products are affected?
When will Zemplar be available again?
Can I still get Zemplar or its generic somewhere?
Is the brand or the generic affected?
What should I do if I take Zemplar?
Still have a question about the Zemplar shortage?
Ask a pharmacist about this shortage →View Paricalcitol Capsule on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (companies listing the same ingredient & form — the "other companies" the rating counts); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.